| 1. |
Peltola H. (1983) Meningococcal disease: still with us. Rev. Infect. Dis.
5, 71–91.
|
| |
| 2. |
Broome C. V. (1986) The carrier state: Neisseria meningitidis. J. Antimicrob. Chemother.
18(Suppl. A), 25–34.
|
| |
| 3. |
Caugant D. A., Froholm L. O., Sacchi C. T., and Selander R. K. (1991) Genetic structure and epidemiology of serogroup B Neisseria meningitidis, in Neisseriae 1990 (Achtman M., Kohl P., Marchal C., Morelli G., Seiler A., and Thiesen B., eds.), Walter de Gruyter, Berlin, pp. 37–42.
|
| |
| 4. |
Maiden M. C. J. and Feavers I. M. (1995) Population genetics and global epidemiology of the human pathogen Neisseria meningitidis, in Population Genetics of Bacteria (Baumberg S., Young J. P. W., Wellington E. M. H., and Saunders J. R., eds.), Cambridge University Press, Cambridge, UK,
pp. 269–293.
|
| |
| 5. |
Whalen C. M., Hockin J. C., Ryan A., and Ashton F. (1995) The changing epidemiology of invasive meningococcal disease in Canada,
1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis. JAMA
273, 390–394.
|
| |
| 6. |
Hart C. A., Cuevas L. E., Marzouk O., Thomson A. P., and Sills J. (1993) Management of bacterial meningitis. J. Antimicrob. Chemother.
32(Suppl. A), 49–59.
|
| |
| 7. |
Begg N. (1995) Outbreak management, in Meningococcal Disease (Cartwright K. A. V., ed.), John Wiley and Sons, Sons, Chichester, UKhichester, UK, pp. 286–305.
|
| |
| 8. |
Cartwright K. A. V. (1995) Meningococcal Disease. John Wiley & Sons, Sons, Chichester, UKhichester, UK.
|
| |
| 9. |
Branham S. E. (1953) Serological relationships among meningococci. Bact. Rev.
17, 175–188.
|
| |
| 10. |
Vedros N. A. (1987) Development of meningococcal serogroups, in Evolution of Meningococcal Disease; vol. II (Vedros N. A., ed.), CRC Press Inc., Boca Raton, FL, pp. 33–37.
|
| |
| 11. |
Frasch C. E., Zollinger W. D., and Poolman J. T. (1985) Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes. Rev. Infect. Dis.
7, 504–510.
|
| |
| 12. |
Moore P. S. and Broome C. V. (1994) Cerebrospinal meningitis epidemics. Sci. Am.
271, 24–31.
|
| |
| 13. |
Lapeyssonnie L. (1963) La meningite cerebrospinale en Afrique. Bull. WHO
28(Suppl.), 53–114.
|
| |
| 14. |
Schwartz B., Moore P. S., and Broome C. V. (1989) Global epidemiology of meningococcal disease. Clin. Microbiol. Rev.
2, 118–124.
|
| |
| 15. |
Achtman M. (1991) Clonal properties of meningococci from epidemic meningitis. Trans. R. Soc. Trop. Med. Hyg.
85(Suppl. 1), 24–31.
|
| |
| 16. |
Achtman M. (1990) Molecular epidemiology of epidemic bacterial meningitis. Rev. Med. Microbiol.
1, 29–38.
|
| |
| 17. |
Wang J.-F., Caugant D. A., Li X., Hu X., Poolman J. T., Crowe B. A., and Achtman M. (1992) Clonal and antigenic analysis of
serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in China. Infect. Immun.
60, 5267–5282.
|
| |
| 18. |
Mohammed I., Nasidi A., Alkali A. S., Garbati M. A., Ajayi-Obe E. K., Audu K. A., et al. (2000) A severe epidemic of meningococcal
meningitis in Nigeria, 1996. Trans. R. Soc. Trop. Med. Hyg.
94, 265–270.
|
| |
| 19. |
Moore P. S., Harrison L. H., Telzak E. E., Ajello G. W., and Broome C. V. (1988) Group A meningococcl carriage in travelers
returning from Saudi Arabia. JAMA
260, 2686–2689.
|
| |
| 20. |
Popovic T., Sacchi C. T., Reeves M. W., Whitney A. M., Mayer L. W., Noble C. A., et al. (2000) Neisseria meningitidis serogroup
W135 isolates associated with the ET-37 complex [letter]. Emerg. Infect. Dis.
6, 428–429.
|
| |
| 21. |
Hansman D. (1983) Meningococcal disease in South Australia: incidence and serogroup distribution 1971-1980. J. Hyg.
90, 49–54.
|
| |
| 22. |
Kaczmarski E. B. (1997) Meningococcal infections in England and Wales. Com-muni. Dis. Rep. Rev.
7, R55–R59.
|
| |
| 23. |
Barquet N., Domingo P., Cayla J. A., Gonzalez J., Rodrigo C., Fernandez-Viladrich P., et al. (1999) Meningococcal disease
in a large urban population (Barcelona, 1987-1992): predictors of dismal prognosis. Barcelona Meningococcal Disease Surveillance
Group. Arch. Intern. Med.
159, 2329–2340.
|
| |
| 24. |
Krizova P., Musilek M., and Kalmusova J. (1997) Development of the epide-miological situation in invasive meningococcal disease
in the Czech Republic caused by emerging Neisseria meningitidis clone ET-15/37. Cent. Eur. J. Public Health
5, 214–218.
|
| |
| 25. |
Kremastinou J., Tzanakaki G., Velonakis E., Voyiatzi A., Nickolaou A., Elton R. A., et al. (1999) Carriage of Neisseria meningitidis and Neisseria lactamica among ethnic Greek school children from Russian immigrant families in Athens. FEMS Immunol. Med. Microbiol.
23, 13–20.
|
| |
| 26. |
Caugant D. A., Mocca L. F., Frasch C. E., Froholm L. O., Zollinger W. D., and Selander R. K. (1987) Genetic structure of Neisseria meningitidis populations in relation to serogroup, serotype, and outer membrane protein pattern. J. Bacteriol.
169, 2781–2792.
|
| |
| 27. |
Caugant D. A., Froholm L. O., Bovre K., Holten E., Frasch C. E., Mocca L. F., et al. (1987) Intercontinental spread of Neisseria meningitidis clones of the ET-5 complex. Antonie van Leeuwenhoek J. Microbiol.
53, 389–394.
|
| |
| 28. |
Maiden M. C. J., Bygraves J. A., Feil E., Morelli G., Russell J. E., Urwin R., et al. (1998) Multilocus sequence typing: a
portable approach to the identification of clones within populations of pathogenic microorganisms. Proc. Natl. Acad. Sci. USA
95, 3140–3145.
|
| |
| 29. |
Caugant D. A., Kristiansen B. E., Froholm L. O., Bovre K., and Selander R. K. (1988) Clonal diversity of Neisseria meningitidis from a population of asymptomatic carriers. Infect. Immun.
56, 2060–2068.
|
| |
| 30. |
Maiden M. C. J. (1993) Population genetics of a transformable bacterium: the influence of horizontal genetical exchange on
the biology of Neisseria meningitidis. FEMS Microbiol. Lett.
112, 243–250.
|
| |
| 31. |
Gupta S., Maiden M. C. J., Feavers I. M., Nee S., May R. M., and Anderson R. M. (1996) The maintenance of strain structure
in populations of recombining infectious agents. Nat. Med.
2, 437–442.
|
| |
| 32. |
Bygraves J. A. and Maiden M. C. J. (1992) Analysis of the clonal relationships between strains of Neisseria meningitidis by pulsed field gel electrophoresis. J. Gen. Microbiol.
138, 523–531.
|
| |
| 33. |
Parkhill J., Achtman M., James K. D., Bentley S. D., Churcher C., Klee S. R., et al. (2000) Complete DNA sequence of a serogroup
A strain of Neisseria meningitidis Z2491. Nature
404, 502–506.
|
| |
| 34. |
Tettelin H., Saunders N. J., Heidelberg J., Jeffries A. C., Nelson K. E., Eisen J. A., et al. (2000) Complete genome sequence
of Neisseria meningitidis serogroup B strain MC58. Science
287, 1809–1815.
|
| |
| 35. |
Carrol E. D., Thomson A. P., Shears P., Gray S. J., Kaczmarski E. B., and Hart C. A. (2000) Performance characteristics of
the polymerase chain reaction assay to confirm clinical meningococcal disease. Arch. Dis. Child
83, 271–273.
|
| |
| 36. |
Pollard A. J. and Levin M. (2000) Vaccines for prevention of meningococcal disease. Pediatr. Infect. Dis. J.
19, 333–444.
|
| |
| 37. |
Gotschlich E. C., Goldschneider I., and Artenstein M.S. (1969) Human immunity to the meningococcus IV. Immunogenicity of group
A and group C meningococcal polysaccharides. J. Exp. Med.
129, 1367–1384.
|
| |
| 38. |
Finne J., Leinonen M., and Makela P.H. (1983) Antigenic similarities between brain components and bacteria causing meningitis:
implications for vaccine development and pathogenesis. Lancet
ii, 355–357.
|
| |
| 39. |
Bjune G., Closs O., Froholm L. O., Gronnesby J. K., Hoiby E. A., and Nokleby H. (1991) Design of clinical trials with an outer
membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway. NIPH. Ann.
14, 81–91.
|
| |
| 40. |
de Moraes J. C., Perkins B. A., Camargo M. C., Hidalgo N. T., Barbosa H. A., Sacchi C. T., et al. (1992) Protective efficacy
of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet
340, 1074–1078.
|
| |